Study concept and design: Abed, Wittert, Middeldorp, Lau, Brooks, Abhayatatna, Kalman, Sanders.
Acquisition of data: Abed, Wittert, Leong, Shirazi, Bahrami, Middeldorp, Antic, Sanders.
Analysis and interpretation of data: Abed, Wittert, Leong, Lorimer.
Drafting of the manuscript: Abed, Wittert, Leong, Sanders.
Critical revision of the manuscript for important intellectual content: Abed, Wittert, Leong, Shirazi, Bahrami, Middeldorp, Lorimer, Lau, Antic, Brooks, Abhayaratna, Kalman, Sanders.
Statistical analysis: Leong, Lorimer.
Administrative, technical, or material support: Bahrami, Shirazi and Middeldorp.
Study supervision: Abed, Wittert, Sanders.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Abed is supported by the Australian Postgraduate Award and an Earl Bakken Electrophysiology Scholarship from the University of Adelaide. Dr Leong reported being supported by a Postdoctoral Fellowship jointly funded by the National Health and Medical Research Council (NHMRC) and National Heart Foundation of Australia (NHFA). Dr Lau reported being supported by a Postdoctoral Fellowship from the NHMRC. Drs Brooks, Abhayaratna, and Sanders reported being supported by the NHFA. Dr Sanders reported being supported by a Practitioner Fellowship from the NHMRC. Dr Antic reported receiving lecture fees from RESMED and Boehringer-Ingleheim. Dr Kalman reported receiving lecture fees from Bard Electrophysiology. Dr Kalman reported receiving research support from Medtronic, St Jude Medical, and Biosense-Webster. Dr Sanders reported serving on the advisory board of Biosense-Webster, Medtronic, St Jude Medical, sanofi-aventis, and Merck Sharpe & Dohme. Dr Sanders reported receiving lecture and/or consulting fees from Biosense-Webster, Medtronic, St Jude Medical, Boston Scientific, Merck Sharpe & Dohme, Biotronik, and sanofi-aventis. Dr Sanders reported receiving research funding from Medtronic, St Jude Medical, Boston Scientific, Biotronik, and Sorin.
Funding/Support: This study was sponsored by the University of Adelaide. It was supported by funds from the Centre of Heart Rhythm Disorders at the University of Adelaide. The meal replacements were provided without cost by Prima Health Solutions Pty Ltd. Prima Health Solutions had no other involvement in the study. OBEMAN was developed by Dr Wittert with funding from Abbott Australia. The IP for the software is fully held by Dr Wittert and was used without the payment of any license fees.
Role of the Sponsor: The design, approval, and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and the decision to submit the manuscript for publication was executed through the employees and students (Abed, Wittert, Leong, Bahrami, Lorimer, Lau, Brooks, and Sanders) and affiliations of The University of Adelaide (Shirazi, Middeldorp, Antic, Abhayaratna, and Kalman), and overseen by it.
Additional Contributions: Paul Dorian, MD (Division of Cardiology, University of Toronto, and St Michael’s Hospital), kindly provided written permission for use of the University of Toronto Atrial Fibrillation Severity Score.
Correction: This article was corrected online January 14, 2014, for a typographical error in Table 1.